An interventional study of ACT with VR and self-treatment VR in Chronic Dizziness, sponsored by Nagoya City University. Completed at 1 site in Japan. Open to participants aged 20 Years to 64 Years. Per ClinicalTrials.gov, last updated 2023-11-15.
Sponsored by Nagoya City University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to examine the effectiveness of group acceptance and commitment therapy with vestibular rehabilitation for chronic dizziness, in comparison with self-treatment vestibular rehabilitation in addition to clinical management.
The purpose of this study is to examine whether group acceptance and commitment therapy combined with vestibular rehabilitation in addition to clinical management for patients with persistent postural-perceptual dizziness is more effective than treatment-as-usual(TAU), which is self-treatment vestibular rehabilitation in addition to clinical management.
228 studies on the registry are indexed under Dizziness; 57 are open to participants now.
This study's enrollment of 66 is above the median of 42 across 172 interventional studies indexed under Dizziness.
Browse Dizziness studies →Nagoya City University is the lead sponsor of 14 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
acceptance and commitment therapy with vestibular rehabilitation in addition to clinical management
Behavioral: ACT with VR · Other: clinical management
self-treatment vestibular rehabilitation in addition to clinical management
Behavioral: self-treatment VR · Other: clinical management
6 weekly 120-minute group sessions of acceptance and commitment therapy with vestibular rehabilitation, and brief (approximately 15 minute) individual follow-up sessions at 1 and 3 months after the group treatment
booklet written on vestibular rehabilitation for self-treatment
clinical management and pharmacotherapy as usual for chronic dizziness
Handicap due to dizziness
The total score of Dizziness Handicap Inventory (DHI) (The DHI scores range from 0 to 100 points. The higher the score, the greater the handicap.)
Time frame: Post-treatment and 1, 3, and 6 months after treatment (The time point of primary interest is 3 months after treatment.)
Response
Decrease in the total score of DHI equal to or more than 11
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Remission
The total score of DHI equal to or less than 14
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Frequency of dizziness-related symptoms
The total score of Vertigo Symptom Scale-short form (VSS-sf) (The VSS-sf scores range from 0 to 60 points. The higher the score, the worse.)
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Anxiety
The anxiety subscale score of Hospital Anxiety and Depression Scale (HADS) (The HADS-anxiety scores range from 0 to 21 points. The higher the score, the worse.)
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Depression
The depression subscale score of HADS (The HADS-depression scores range from 0 to 21 points. The higher the score, the worse.)
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Recovery process
The total score of Recovery Assessment Scale (RAS) (The RAS scores range from 24 to 120 points. The higher the score, the better.)
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Health-related quality of life
The score of EuroQOL 5 dimensions 5-level (EQ-5D-5L) (The EQ-5D-5L scores range from 0 to 1. The higher the score, the better.)
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Valued living (progress, obstruction)
The each subscale score of Valuing Questionnaire (VQ) (The scores for both VQ-progress and VQ-obstruction range from 0 to 30. The higher the VQ-progress score, the better; the higher the VQ-obstruction score, the worse.)
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Cognitive fusion
The total score of Cognitive Fusion Questionnaire (CFQ) (The CFQ scores range from 7 to 49 points. The higher the score, the worse.)
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Somatic symptom burden
The total score of Somatic Symptom Scale-8 (SSS-8) (The SSS-8 scores range from 0 to 32. The higher the score, the worse.)
Time frame: Post-treatment and 1, 3, and 6 months after treatment
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Apr 2017 to primary completion in Oct 2021, 54 months.
Of 84 non-industry interventional studies with no phase under Dizziness, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's 54 months is above that.
Counting every sponsor, half of 92 studies reached it within 19 months; a quarter within 8 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nagoya City University